Tudor Investment Corp’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,214
Closed -$116K 1640
2024
Q1
$116K Buy
+43,214
New +$116K ﹤0.01% 1360
2023
Q4
Sell
-72,525
Closed -$71.1K 1616
2023
Q3
$71.1K Hold
72,525
﹤0.01% 1403
2023
Q2
$101K Sell
72,525
-49,456
-41% -$68.7K ﹤0.01% 1429
2023
Q1
$194K Buy
121,981
+37,032
+44% +$58.9K ﹤0.01% 1385
2022
Q4
$529K Buy
84,949
+13,505
+19% +$84.1K 0.01% 1098
2022
Q3
$479K Buy
71,444
+25,547
+56% +$171K 0.01% 1125
2022
Q2
$292K Sell
45,897
-26,627
-37% -$169K 0.01% 1254
2022
Q1
$337K Buy
72,524
+168
+0.2% +$781 0.01% 1233
2021
Q4
$362K Buy
72,356
+1,785
+3% +$8.93K 0.01% 1265
2021
Q3
$850K Buy
70,571
+41,237
+141% +$497K 0.01% 929
2021
Q2
$620K Hold
29,334
0.01% 1029
2021
Q1
$823K Sell
29,334
-9,446
-24% -$265K 0.02% 919
2020
Q4
$1.01M Buy
38,780
+29,421
+314% +$765K 0.03% 687
2020
Q3
$348K Buy
+9,359
New +$348K 0.02% 934
2019
Q3
Sell
-9,890
Closed -$460K 1147
2019
Q2
$460K Buy
9,890
+4,747
+92% +$221K 0.01% 731
2019
Q1
$206K Sell
5,143
-5,531
-52% -$222K 0.01% 985
2018
Q4
$491K Buy
+10,674
New +$491K 0.01% 589
2017
Q4
Sell
-42,954
Closed -$2.15M 1120
2017
Q3
$2.15M Buy
+42,954
New +$2.15M 0.05% 188
2015
Q4
Sell
-23,100
Closed -$545K 1543
2015
Q3
$545K Buy
+23,100
New +$545K 0.02% 671
2015
Q2
Sell
-5,903
Closed -$547K 1492
2015
Q1
$547K Buy
+5,903
New +$547K 0.02% 675
2013
Q4
Sell
-10,000
Closed -$189K 1277
2013
Q3
$189K Buy
+10,000
New +$189K 0.01% 736